How to Rule Out Pulmonary Embolism
Use validated clinical prediction rules (Wells or revised Geneva score) to stratify pretest probability, then apply PERC criteria for low-risk patients or obtain high-sensitivity D-dimer testing (with age-adjusted cutoffs for patients >50 years) to safely exclude PE without imaging. 1
Step 1: Assess Pretest Clinical Probability
- Apply a validated clinical prediction rule such as the Wells score or revised Geneva score to categorize patients into low (
10% PE prevalence), intermediate (30%), or high (~65%) probability groups 1, 2 - The revised Geneva score assigns points for: previous PE/DVT (1 point), heart rate 75-94 bpm (1 point) or ≥95 bpm (2 points), surgery/fracture within past month (1 point), hemoptysis (1 point), active cancer (1 point), unilateral lower-limb pain (1 point), pain on deep venous palpation with unilateral edema (1 point), and age >65 years (1 point) 1
- Clinical gestalt performs equally well as formal prediction rules when used by experienced clinicians for risk stratification 1
- Using the two-level classification, PE-unlikely is defined as Wells score 0-4 or revised Geneva score 0-2, with PE prevalence of approximately 12% 1
Step 2: Apply PERC Rule for Low-Risk Patients
- For patients with LOW pretest probability only, apply the Pulmonary Embolism Rule-Out Criteria (PERC) to identify those who need no further testing 1
- All eight PERC criteria must be met: age <50 years, pulse <100 bpm, SaO₂ >94%, no unilateral leg swelling, no hemoptysis, no recent trauma or surgery, no history of VTE, and no oral hormone use 1
- If all PERC criteria are met, PE can be safely excluded without D-dimer testing or imaging, as the risk of PE (<1%) is lower than the risks of testing 1
- If any PERC criterion is not met, proceed to D-dimer testing 1
Important Caveat About PERC
- PERC should only be applied to patients already determined to have LOW clinical probability by a prediction rule or gestalt assessment 1
- One external validation study found a 6.4% PE prevalence among PERC-negative patients with low pretest probability, suggesting PERC may not be universally safe in all populations, particularly those with higher baseline PE prevalence 3
- The pooled sensitivity of PERC across 12 studies was 97% with specificity of 22%, meaning PERC can safely avoid 22% of D-dimer tests 1
Step 3: D-Dimer Testing Strategy
For Low or Intermediate Pretest Probability Patients
- Obtain high-sensitivity D-dimer (ELISA or ELISA-derived assays with ≥95% sensitivity) as the initial diagnostic test in patients with low pretest probability who do not meet all PERC criteria, or in patients with intermediate pretest probability 1
- Do NOT use imaging studies as the initial test in patients with low or intermediate pretest probability 1
Age-Adjusted D-Dimer Cutoffs
- For patients >50 years old, use age-adjusted D-dimer thresholds (age × 10 ng/mL) rather than the generic 500 ng/mL cutoff 1
- Age-adjusted cutoffs increase the number of patients in whom PE can be excluded from 6.4% to 30% without additional false-negative findings, while maintaining sensitivity >97% 1, 4
- D-dimer specificity decreases to only 10% in patients >80 years using standard cutoffs, making age adjustment particularly important in elderly patients 1
Interpreting D-Dimer Results
- If D-dimer is below the age-adjusted cutoff (or <500 ng/mL if age ≤50 years), PE is excluded and no imaging is needed 1
- If D-dimer is elevated, proceed to imaging with CT pulmonary angiography 1
- The negative predictive value of normal D-dimer combined with low clinical probability is 99% for PE 4, 5
D-Dimer Limitations
- D-dimer has high sensitivity (96%) but low specificity (35%) for PE, making it excellent for ruling out but poor for ruling in PE 4
- D-dimer is frequently elevated regardless of PE status in hospitalized patients, post-surgical patients, pregnant women, cancer patients, and those with severe infection or inflammatory disease 1
- The number needed to test rises from 3 in general emergency department populations to >10 in these special populations 1
Step 4: Imaging for High Pretest Probability
- For patients with HIGH pretest probability, proceed directly to imaging without D-dimer testing, as a negative D-dimer will not obviate the need for imaging 1
- CT pulmonary angiography (CTPA) is the preferred imaging modality when available and no contraindication to contrast exists 1, 2
- Reserve ventilation-perfusion (V/Q) scans for patients with contraindication to CTPA (renal insufficiency, contrast allergy) or when CTPA is unavailable 1
- V/Q scanning is associated with lower radiation exposure than CTPA and may be preferred in younger patients and pregnancy 5
Common Pitfalls to Avoid
- Never apply PERC to patients with intermediate or high pretest probability - it is only validated for low-risk patients 1
- Never use a positive D-dimer alone to diagnose PE - confirmation with imaging is always required 4
- Do not obtain D-dimer in high pretest probability patients - proceed directly to imaging 1
- Avoid ordering D-dimer in populations where results are likely positive regardless of PE status (hospitalized, post-surgical, pregnant patients) as specificity is too low to be useful 1
- Do not use point-of-care D-dimer assays in high pretest probability patients due to lower sensitivity (88% vs 95% for ELISA) 4
- Remember that many population-level risk factors (family history, postpartum period, lower-extremity fracture, pregnancy itself, congestive heart failure, stroke) are not included in validated prediction rules because they did not add to predictive performance 1